Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years-Reference-Cited by-同舟云学术

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years

Published:2020-05 Issue:9 Volume:13 Page:1100-1109
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Buiten Rosaly A.,Ploumen Eline H.,Zocca Paolo,Doggen Carine J.M.,Jessurun Gillian A.J.,Schotborgh Carl E.,Roguin Ariel,Danse Peter W.,Benit Edouard,Aminian Adel,van Houwelingen K. Gert,Schramm Alexander R.,Stoel Martin G.,Somi Samer,Hartmann Marc,Linssen Gerard C.M.,von Birgelen Clemens

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. 5-Year safety and efficacy of Resolute zotarolimus-eluting stent: the RESOLUTE global clinical trial program;Yeh;J Am Coll Cardiol Intv,2017

2. Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial;von Birgelen;Lancet,2014

3. Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial;Raungaard;Lancet,2015

4. Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial;von Birgelen;Lancet,2016

5. Outcomes in patients treated with thin-strut, very thin-strut, or ultrathin-strut drug-eluting stents in small coronary vessels: a prespecified analysis of the randomized BIO-RESORT trial;Buiten;JAMA Cardiol,2019

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes with biodegradable versus durable polymer drug-eluting stents in patients with ST-elevation myocardial infarction;Cardiovascular Revascularization Medicine;2024-08

2. Comparative effectiveness of ultrathin vs. standard strut drug-eluting stents: insights from a large-scale meta-analysis with extended follow-up;European Journal of Medical Research;2024-07-27

3. Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design;BMC Cardiovascular Disorders;2024-06-24

4. Final 5‐year report of BIONYX comparing the thin‐composite wire‐strut zotarolimus‐eluting stent versus ultrathin‐strut sirolimus‐eluting stent;Catheterization and Cardiovascular Interventions;2024-05-07

5. Comparative Effectiveness of Ultrathin vs. Standard Strut Drug-Eluting Stents: Insights from a Large-Scale Meta-Analysis with Extended Follow-up;2024-04-01